Effects of nociceptin on the spread and seizure activity in the rat amygdala kindling model: Their correlations with 3H-leucyl-nociceptin binding

[1]  E. Prinssen,et al.  Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications. , 2007, Current drug targets.

[2]  D. Thakker,et al.  Orphanin FQ/Nociceptin Potentiates [D-Ala2,N-Me-Phe4,Gly5-ol]-Enkephalin–Induced μ-Opioid Receptor Phosphorylation , 2005, Molecular Pharmacology.

[3]  T. Yeh,et al.  Heterodimerization of opioid receptor‐like 1 and µ‐opioid receptors impairs the potency of µ receptor agonist , 2005, Journal of neurochemistry.

[4]  M. Mazzuferi,et al.  Kainate seizures increase nociceptin/orphanin FQ release in the rat hippocampus and thalamus: a microdialysis study , 2004, Journal of neurochemistry.

[5]  Wei-min Li,et al.  Inhibition of nociceptin/orphanin FQ on penicillin-induced seizures in rats , 2004, Brain Research.

[6]  M. Printz,et al.  Rat strain-dependent effects of repeated stress on the acoustic startle response , 2003, Behavioural Brain Research.

[7]  J. Moreau,et al.  Impact of environmental housing conditions on the emotional responses of mice deficient for nociceptin/orphanin FQ peptide precursor gene , 2003, Behavioural Brain Research.

[8]  M. Mazzuferi,et al.  Delayed epileptogenesis in nociceptin/orphanin FQ-deficient mice , 2003, Neuroreport.

[9]  R. Reinscheid,et al.  Involvement of the Neuropeptide Nociceptin/Orphanin FQ in Kainate Seizures , 2002, The Journal of Neuroscience.

[10]  D. Lambert,et al.  Effects of chronic nociceptin/orphanin FQ exposure on cAMP accumulation and receptor density in Chinese hamster ovary cells expressing human nociceptin/orphanin FQ receptors. , 2002, European journal of pharmacology.

[11]  D. Filliol,et al.  Quantitative autoradiographic mapping of opioid receptors in the brain of δ-opioid receptor gene knockout mice , 2002, Brain Research.

[12]  R. Reinscheid,et al.  Involvement of the Neuropeptide Orphanin FQ/Nociceptin in Kainate and Kindling Seizures and Epileptogenesis , 2002, Epilepsia.

[13]  M. Sieklucka-Dziuba,et al.  Nociceptin, OP4 receptor ligand in different models of experimental epilepsy , 2002, Peptides.

[14]  G. Pasternak,et al.  The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. , 2001, Pharmacological reviews.

[15]  R. Acevedo,et al.  Orphanin-FQ/nociceptin inhibits kindling epileptogenesis and enhances hippocampal feed-forward inhibition , 2001, Neuroscience.

[16]  J. Pintar,et al.  Quantitative autoradiographic mapping of the ORL1, μ-, δ- and κ-receptors in the brains of knockout mice lacking the ORL1 receptor gene , 2001, Brain Research.

[17]  J. Pintar,et al.  Morphine tolerance and dependence in nociceptin/orphanin fq transgenic knock-out mice , 2001, Neuroscience.

[18]  H. Fields,et al.  A Cellular Mechanism for the Bidirectional Pain-Modulating Actions of Orphanin FQ/Nociceptin , 2000, Neuron.

[19]  G. Adam,et al.  A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Salvadori,et al.  Characterization of [Nphe1]nociceptin(1‐13)NH2, a new selective nociceptin receptor antagonist , 2000, British journal of pharmacology.

[21]  G. Pasternak,et al.  Identification of a high‐affinity orphanin FQ/nociceptin(1–11) binding site in mouse brain , 1999, Synapse.

[22]  E. Ongini,et al.  Nociceptin and the ORL‐1 ligand [Phe1ψ (CH2‐NH)Gly2]nociceptin(1‐13)NH2 exert anti‐opioid effects in the Freund's adjuvant‐induced arthritic rat model of chronic pain , 1999, British journal of pharmacology.

[23]  H. Akil,et al.  Opioid receptor‐like (ORL1) receptor distribution in the rat central nervous system: Comparison of ORL1 receptor mRNA expression with 125I‐[14Tyr]‐orphanin FQ binding , 1999, The Journal of comparative neurology.

[24]  T. Funabashi,et al.  Fos expression in gonadotropin-releasing hormone neurons by naloxone or bicuculline in intact male rats , 1999, Brain Research.

[25]  B. Undem,et al.  Naloxone blocks endomorphin‐1 but not endomorphin‐2 induced inhibition of tachykinergic contractions of guinea‐pig isolated bronchus , 1999, British journal of pharmacology.

[26]  H L Wang,et al.  A Conserved Arginine in the Distal Third Intracellular Loop of the μ‐Opioid Receptor Is Required for G Protein Activation , 1999, Journal of neurochemistry.

[27]  M. Simonato,et al.  Limbic seizures increase pronociceptin mRNA levels in the thalamic reticular nucleus. , 1999, Neuroreport.

[28]  G. Pasternak,et al.  Identification and differential regional expression of KOR‐3/ORL‐1 gene splice variants in mouse brain , 1998, FEBS letters.

[29]  S. Salvadori,et al.  Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay , 1998, British journal of pharmacology.

[30]  G. Pasternak,et al.  Antinociceptive analogs of orphanin FQ/nociceptin(1-11). , 1998, Life sciences.

[31]  T. Manabe,et al.  Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors , 1998, Nature.

[32]  W. Löscher,et al.  Limbic epileptogenesis alters the anticonvulsant efficacy of phenytoin in Sprague–Dawley rats , 1998, Epilepsy Research.

[33]  J. Schneider,et al.  Analgesic effects of 1′,1′ dimethylheptyl-Δ8-THC-11-oic acid (CT3) in mice , 1998 .

[34]  F. Monsma,et al.  Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[35]  D. Grandy,et al.  Orphanin FQ is a functional anti-opioid peptide , 1996, Neuroscience.

[36]  D. Grandy,et al.  Orphanin FQ acts as a supraspinal, but not a spinal, anti‐opioid peptide , 1996, Neuroreport.

[37]  D. Grandy,et al.  Functional antagonism of μ-, δ- and κ-opioid antinociception by orphanin FQ , 1996, Neuroscience Letters.

[38]  J. Engel,et al.  Effects of chronic morphine pretreatment on amygdaloid kindling development, postictal seizure and suppression and benzodiazepine receptor binding in rats , 1996, Epilepsy Research.

[39]  D. Grandy,et al.  Orphanin FQ: A Neuropeptide That Activates an Opioidlike G Protein-Coupled Receptor , 1995, Science.

[40]  Marc Parmentier,et al.  Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor , 1995, Nature.

[41]  G Vassart,et al.  ORL1, a novel member of the opioid receptor family , 1994, FEBS letters.

[42]  J. Engel,et al.  Interictal behavioral disturbances: a search for molecular substrates. , 1992, Epilepsy research. Supplement.

[43]  J. Nobrega,et al.  Autoradiographic analysis of benzodiazepine binding in entorhinal-kindled rat brains , 1989, Brain Research.

[44]  J. McNamara,et al.  gamma-Aminobutyric acid and benzodiazepine receptors in the kindling model of epilepsy: a quantitative radiohistochemical study , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[45]  J. Engel,et al.  Interictal EEG spikes correlate with decreased, rather than increased, epileptogenicity in amygdaloid kindled rats , 1980, Brain Research.

[46]  J. Engel,et al.  Endogenous opiods may mediate post-ictal behavioral depression in amygdaloid-kindled rats , 1979, Brain Research.

[47]  R. Racine,et al.  Modification of seizure activity by electrical stimulation. II. Motor seizure. , 1972, Electroencephalography and clinical neurophysiology.